2seventy bio, Inc.

Informe acción NasdaqGS:TSVT

Capitalización de mercado: US$163.0m

2seventy bio Dirección

Dirección controles de criterios 0/4

El CEO de 2seventy bio es Chip Baird , nombrado en Apr 2024, tiene una permanencia de menos de un año. compensación anual total es $2.93M, compuesta por 17.7% salario y 82.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.12% de las acciones de la empresa, por valor de $187.75K. La antigüedad media del equipo directivo y de la junta directiva es de 0.6 años y 1.2 años, respectivamente.

Información clave

Chip Baird

Chief Executive Officer (CEO)

US$2.9m

Compensación total

Porcentaje del salario del CEO17.7%
Permanencia del CEOless than a year
Participación del CEO0.1%
Permanencia media de la direcciónless than a year
Promedio de permanencia en la Junta Directiva1.2yrs

Actualizaciones recientes de la dirección

Recent updates

Analysts Have Been Trimming Their 2seventy bio, Inc. (NASDAQ:TSVT) Price Target After Its Latest Report

Nov 15
Analysts Have Been Trimming Their 2seventy bio, Inc. (NASDAQ:TSVT) Price Target After Its Latest Report

There's No Escaping 2seventy bio, Inc.'s (NASDAQ:TSVT) Muted Revenues

Oct 03
There's No Escaping 2seventy bio, Inc.'s (NASDAQ:TSVT) Muted Revenues

2seventy bio, Inc.'s (NASDAQ:TSVT) Share Price Is Matching Sentiment Around Its Revenues

Jul 04
2seventy bio, Inc.'s (NASDAQ:TSVT) Share Price Is Matching Sentiment Around Its Revenues

Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term

May 11
Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term

2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround

Apr 03

These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts

Mar 07
These Analysts Just Made A Massive Downgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) EPS Forecasts

2seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%

Feb 06
2seventy bio, Inc. (NASDAQ:TSVT) Held Back By Insufficient Growth Even After Shares Climb 49%

Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation

Jan 17
Here's Why We're Watching 2seventy bio's (NASDAQ:TSVT) Cash Burn Situation

2seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth

Dec 13
2seventy bio, Inc. (NASDAQ:TSVT) Shares Fly 44% But Investors Aren't Buying For Growth

Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts

May 05
Industry Analysts Just Made A Dazzling Upgrade To Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts

Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%

Mar 21
Industry Analysts Just Upgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Revenue Forecasts By 12%

2seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

Mar 19
2seventy bio, Inc. (NASDAQ:TSVT) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

Oct 04
We're Keeping An Eye On 2seventy bio's (NASDAQ:TSVT) Cash Burn Rate

2seventy Bio: This Spinoff In The CAR-T Space Is Attractive

Sep 08

2seventy bio Prospects

Aug 23

Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

Aug 12
Time To Worry? Analysts Just Downgraded Their 2seventy bio, Inc. (NASDAQ:TSVT) Outlook

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Chip Baird en comparación con los beneficios de 2seventy bio?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

-US$95m

Jun 30 2024n/an/a

-US$156m

Mar 31 2024n/an/a

-US$223m

Dec 31 2023US$3mUS$518k

-US$218m

Sep 30 2023n/an/a

-US$184m

Jun 30 2023n/an/a

-US$180m

Mar 31 2023n/an/a

-US$215m

Dec 31 2022n/an/a

-US$254m

Sep 30 2022n/an/a

-US$292m

Jun 30 2022n/an/a

-US$284m

Mar 31 2022n/an/a

-US$291m

Dec 31 2021US$2mUS$491k

-US$292m

Sep 30 2021n/an/a

-US$308m

Jun 30 2021n/an/a

-US$320m

Mar 31 2021n/an/a

-US$222m

Dec 31 2020US$2mUS$475k

-US$120m

Compensación vs. Mercado: La compensación total de Chip($USD2.93M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD1.46M).

Compensación vs. Ingresos: La compensación de Chip ha aumentado mientras la empresa no es rentable.


CEO

Chip Baird (52 yo)

less than a year

Permanencia

US$2,927,118

Compensación

Mr. William D. Baird III, also known as Chip, serves as Chief Executive Officer, President and Director of 2seventy bio, Inc. since April 1, 2024. He was Principal Financial Officer and Principal Accountin...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
William Baird
CEO, President & Directorless than a yearUS$2.93m0.12%
$ 187.7k
Victoria Eatwell
Chief Financial Officerless than a yearsin datos0.66%
$ 1.1m
Jessica Snow
Senior VP of Quality and Head of Operationsless than a yearsin datos0.30%
$ 492.2k
Anna Truppel-Hartmann
Chief Medical Officerless than a yearsin datossin datos

0.6yrs

Permanencia media

45yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de TSVT no se considera experimentado ( 0.6 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
William Baird
CEO, President & Directorless than a yearUS$2.93m0.12%
$ 187.7k
Eli Casdin
Independent Directorless than a yearsin datossin datos
Nick Leschly
Chairman of the Boardless than a yearUS$9.08m1.43%
$ 2.3m
Charles Newton
Independent Directorless than a yearsin datossin datos
Marcela Maus
Independent Director3.1yrsUS$290.00k0.028%
$ 46.1k
Denice Torres
Lead Independent Director3.1yrsUS$304.00k0.038%
$ 61.7k
Sarah J. Glickman
Independent Director3.1yrsUS$303.00k0.028%
$ 46.1k
Wei Lin
Independent Director1.7yrsUS$622.05k0.019%
$ 30.8k

1.2yrs

Permanencia media

53yo

Promedio de edad

Junta con experiencia: La junta directiva de TSVT no se considera experimentada (1.2 años de permanencia promedio), lo que sugiere una nueva junta directiva.